Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis

The current psychopharmacological treatment approaches for major depression focus on monoaminergic interventions, which are ineffective in a large proportion of patients. Globally, treatment-resistant bipolar depression (TRBD) affects up to 33% of depressive patients receiving treatment. Certain nee...

Full description

Bibliographic Details
Main Authors: Adam Włodarczyk, Wiesław Jerzy Cubała
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/2/67